We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.36%
This Fund
S&P 500
This Quarter Est. Return
+5.74%
1 Year Est. Return
+16.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$128B
AUM Growth
+$15.2B
Cap. Flow
+$9.11B
Cap. Flow %
7.13%
Top 10 Hldgs %
13.82%
Holding
11,531
New
1,109
Increased
4,588
Reduced
4,144
Closed
1,087

Sector Composition

Rank Sector Weight
1 Energy 8.83%
2 Technology 6.7%
3 Healthcare 6.28%
4 Financials 6.28%
5 Industrials 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NASB
8276
DELISTED
NASB FINL INC
NASB
$17K ﹤0.01%
708
-1,368
-66% -$31.6K
HMH
8277
DELISTED
HELIOS MULTI-SECTOR HIGH INCOME FD, INC
HMH
$17K ﹤0.01%
2,333
-426
-15% -$2.97K
CUO
8278
DELISTED
Continental Materials Corporation
CUO
$17K ﹤0.01%
1,092
+710
+186% +$12K
WLH
8279
DELISTED
WILLIAM LYON HOMES
WLH
$17K ﹤0.01%
566
-1,651
-74% -$44.4K
LONG
8280
DELISTED
ELONG, INC. AMERICAN DEPOSITARY SHARES
LONG
$17K ﹤0.01%
752
-948
-56% -$14.3K
BUND
8281
DELISTED
PIMCO ETF TR PIMCO GERMANY BD INDEX ETF
BUND
$17K ﹤0.01%
+157
New +$16.9K
ICI
8282
DELISTED
iPath Optimized Currency Carry ETN
ICI
$17K ﹤0.01%
407
-239
-37% -$10K
ACNB icon
8283
ACNB Corp
ACNB
$649M
$16K ﹤0.01%
811
+471
+139% +$9.13K
ADTN icon
8284
CALL
Adtran
ADTN
$682M
$16K ﹤0.01%
700
+100
+17% +$2.26K
AGEN
8285
Agenus
AGEN
$329M
$16K ﹤0.01%
259
-6,808
-96% -$394K
AKO.A icon
8286
Embotelladora Andina Series A
AKO.A
$3.58B
$16K ﹤0.01%
874
+489
+127% +$9.31K
ALLT icon
8287
CALL
Allot
ALLT
$367M
$16K ﹤0.01%
+1,200
New +$15.7K
AXDX
8288
PUT
DELISTED
Accelerate Diagnostics
AXDX
$16K ﹤0.01%
60
+50
+500% +$10.9K
BAP icon
8289
CALL
Credicorp
BAP
$32B
$16K ﹤0.01%
100
-4
-4% -$599
CATX icon
8290
Perspective Therapeutics
CATX
$341M
$16K ﹤0.01%
500
-1,656
-77% -$41.5K
CATY icon
8291
Cathay General Bancorp
CATY
$4.21B
$16K ﹤0.01%
608
-600
-50% -$14.8K
CBZ icon
8292
CBIZ
CBZ
$3B
$16K ﹤0.01%
1,770
-481
-21% -$4.19K
CECO icon
8293
PUT
Ceco Environmental
CECO
$3.83B
$16K ﹤0.01%
+1,000
New +$15.3K
CRL icon
8294
CALL
Charles River Laboratories
CRL
$11.3B
$16K ﹤0.01%
300
-1,200
-80% -$65.8K
EET icon
8295
PUT
ProShares Ultra MSCI Emerging Markets
EET
$34.7M
$16K ﹤0.01%
+200
New +$15.5K
ERNA icon
8296
Eterna Therapeutics
ERNA
$4.05M
0
FBIN icon
8297
CALL
Fortune Brands Innovations
FBIN
$5.88B
$16K ﹤0.01%
468
+234
+100% +$8.03K
FCF icon
8298
CALL
First Commonwealth Financial
FCF
$2.18B
$16K ﹤0.01%
1,700
-20,000
-92% -$175K
FSFG
8299
DELISTED
First Savings Financial Group
FSFG
$16K ﹤0.01%
1,923
+336
+21% +$2.65K
FTK icon
8300
PUT
Flotek Industries
FTK
$847M
$16K ﹤0.01%
83

Similar funds

UBS's Q2 2014 Portfolio in Review

As of Q2 2014, UBS held 11,531 positions worth $128B, up 14% from $113B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS deployed $9.11B of net new capital in Q2 2014, opening 1,109 new positions and adding to 4,588 existing holdings. Its largest new stake was JD.com: 3,966,156 shares worth $113M.

By sector, the portfolio is most concentrated in Energy at 8.8% of assets, down from 9% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Baker Hughes, an estimated $755M trimmed.

  • UBS's largest Q2 2014 buy was JD.com: 3,966,156 shares worth $113M.
  • UBS added most to State Street SPDR S&P 500 ETF Trust in Q2 2014, an estimated $1.71B increase.
  • UBS's biggest Q2 2014 reduction was Baker Hughes, cutting an estimated $755M.
  • UBS fully exited KKR FINANCIAL HOLDINGS LLC COM in Q2 2014, selling an estimated $47.8M.
  • UBS's ten largest holdings make up 14% of its $128B portfolio in Q2 2014.
  • UBS opened 1,109 new positions and closed 1,087 in Q2 2014.
  • UBS's portfolio value rose 14% quarter-over-quarter to $128B.

Based on UBS's 13F filing for Q2 2014, filed 14 Aug 2014.